Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
Melanoma/Skin Cancer
•
Medical Oncology
What is your approach to treating inoperable mucosal melanoma of the head and neck region?
What is the preferred dose, fractionation, and role of concurrent chemo?
Answer from: Radiation Oncologist at Academic Institution
It is often nasal cavity/paranasal sinuses, so 1.2 Gy BID to 74.4 Gy and electively treat the neck. Otherwise 70 Gy/35 fx/30 treatment days SIB.
Comments
Radiation Oncologist at The Toledo Clinic
Do you treat only the ipsilateral neck?
Radiation Oncologist at University of Florida
I would treat the ipsilateral neck electively.
Radiation Oncologist at The Toledo Clinic
Thank you.
Radiation Oncologist at Providence St. Mary Medical Center
Role for immunotherapy? Neoadj or Adj?
10987
10991
10993
14435
Sign in or Register to read more
675
Related Questions
How would you approach management of a large, fungating squamous cell carcinoma of the auricle if surgical management is not desired by the patient?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
In what situations would you recommend adjuvant radiation therapy for patients with locally advanced and/or recurrent basal cell carcinoma that receive vismodegib followed by surgery?
Would you consider adjuvant immunotherapy for a patient with high-risk (N3 nodes) Merkel cell carcinoma following definitive surgical resection and adjuvant radiation therapy?
How would you manage a large area of multiple, recurrent cutaneous squamous cell carcinomas of the scalp with ulcerations and non-healing areas despite cryotherapy, multiple Mohs procedures, and 5-FU?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?
When would you consider larynx preservation in patients with T4N+ SCC of the larynx?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
How do you treat SNUC?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
Do you treat only the ipsilateral neck?
I would treat the ipsilateral neck electively.
Thank you.
Role for immunotherapy? Neoadj or Adj?